Generation and characterization of mesenchymal stromal cells for clinical application

被引:1
|
作者
Sensebe, L. [1 ]
机构
[1] EFS Ctr Atlantique, Dept Res, Tours 3, France
关键词
clinical trials; controls; GMP; Mesenchymal Stem Cells; HUMAN BONE-MARROW; UMBILICAL-CORD BLOOD; ADULT STEM-CELLS; HUMAN ADIPOSE-TISSUE; EX-VIVO EXPANSION; IN-VITRO; PROGENITOR CELLS; OSTEOGENESIS IMPERFECTA; T-CELLS; GROWTH;
D O I
10.1111/j.1751-2824.2009.01225.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Mesenchymal Stem Cells/Multipotent Marrow Stromal Cells (MSC) are multipotent adult stem cells harboring a wide range of differentiation capacities as well as non-HLA restricted immunosuppressive properties, leading to an increase in their uses for immunomodulation and regenerative medicine. MSC are generally cultivated from bone marrow (BM). Alternative sources (e.g. adipose tissue or umbilical cord) are rapidly developing. Considering the starting material used, the differentiation potential may be different, in example adipose tissue derived MSC exhibit a greater potential for endothelium repair. Whatever the sources of MSC, a first step of adherence to plastic is required. When seeding, the cell density is of major importance acting on growth speed, cell amplification, and differentiation potential. Considering medium used, until now serum free media are not available to cultivate MSC for clinical application. Standard process with FCS without any growth factor supplementation is effective but time consuming, sometime failing, and not totally secure. Although processes using recombinant growth factors (e.g. FGF2) or platelet lysate have demonstrated their interest, definitive standards to produce clinical-grade MSC are still lacking. To reach GMP standards, two major steps have to be done. First, MSC cultures need to be done in closed system; this step is not easy to perform. Second, the controls of produced batches have to ensure efficacy and safety. Now, the controls are principally based on FACS analysis and the expected CD731(pos)CD105(pos)CD90(pos)CD45(neg) MSC phenotype is easily obtained. But the major problem remains the lack of fully validated controls of the final cell product efficacy and safety. Considering the genetic stability of MSC during culture processes, whatever the culture method, aneuploidy could occur during clinical-grade production of BM-MSC but does not lead to cell transformation. But these results should lead to develop more accurate and powerful controls of all MSC in cultures.
引用
收藏
页码:31 / 36
页数:6
相关论文
共 50 条
  • [11] Immunoregulatory properties of clinical grade mesenchymal stromal cells: evidence, uncertainties, and clinical application
    Cédric Ménard
    Karin Tarte
    [J]. Stem Cell Research & Therapy, 4
  • [12] Mesenchymal Stem/Stromal Cells Therapy for Metabolic Syndrome: Potential Clinical Application?
    Huang, Xiuyi
    Liu, Yunchong
    Li, Zilun
    Lerman, Lilach O.
    [J]. STEM CELLS, 2023, 41 (10) : 893 - 906
  • [13] Application of mesenchymal stromal cells in urological diseases
    Montzka, Katrin
    Heidenreich, Axel
    [J]. BJU INTERNATIONAL, 2010, 105 (03) : 309 - 312
  • [14] The Clinical Trials of Mesenchymal Stromal Cells Therapy
    Kouchakian, Mohammad Reza
    Baghban, Neda
    Moniri, Seyedeh Farzaneh
    Baghban, Mandana
    Bakhshalizadeh, Shabnam
    Najafzadeh, Vahid
    Safaei, Zahra
    Izanlou, Safoura
    Khoradmehr, Arezoo
    Nabipour, Iraj
    Shirazi, Reza
    Tamadon, Amin
    [J]. STEM CELLS INTERNATIONAL, 2021, 2021
  • [15] Clinical application of mesenchymal multipotent stromal cells in treatment of steroid-induced osteonecrosis
    Vaegler, M.
    Tzaribatchev, N.
    Reize, P.
    Rudert, M.
    Handgretinger, R.
    Mueller, I.
    [J]. KLINISCHE PADIATRIE, 2007, 219 (03): : 194 - 194
  • [16] Influence of temperature, time and different media on mesenchymal stromal cells shipped for clinical application
    Bronzini, I.
    Patruno, M.
    Iacopetti, I.
    Martinello, T.
    [J]. VETERINARY JOURNAL, 2012, 194 (01): : 121 - 123
  • [17] Basic Biology and Clinical Application of Multipotent Mesenchymal Stromal Cells: From Bench to Bedside
    Kuci, Selim
    Henschler, Reinhard
    Mueller, Ingo
    Biagi, Ettore
    Meisel, Roland
    [J]. STEM CELLS INTERNATIONAL, 2012, 2012
  • [18] Mesenchymal stromal cells and the acute respiratory distress syndrome (ARDS): challenges for clinical application
    Millar, J. E.
    Fraser, J. F.
    McAuley, D. F.
    [J]. THORAX, 2015, 70 (07) : 611 - 612
  • [19] Clinical Application of Bone Marrow Mesenchymal Stem/Stromal Cells to Repair Skeletal Tissue
    Arthur, Agnieszka
    Gronthos, Stan
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (24) : 1 - 27
  • [20] VALIDATION AND GMP PRODUCTION OF MESENCHYMAL STROMAL CELLS BATCHES FOR CLINICAL APPLICATION IN ORTHOPEDICS AND RHEUMATOLOGY
    Codinach, M.
    Blanco, M.
    Torrico, C.
    Vives, J.
    Casamayor-Genesca, A.
    Lopez, J.
    Coll, R.
    Garcia, J.
    Pla, A.
    [J]. CYTOTHERAPY, 2014, 16 (04) : S45 - S46